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full agonists, as well as the modulation of activation by positive allosteric mod-
ulators (PAMs). Finally, our work provides a general model for the activation
process of mGluRs.
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Biased agonism, that is the ligand-dependent selectivity for specific signaling
pathways in a G protein coupled receptor (GPCR), is an emerging, promising
strategy for the development of safer drugs. In the case of the kappa opioid re-
ceptor (KOPr), its preferential activation of G-protein versus b-arrestin has
been proposed to provide a more direct route to discovering non-addictive
opioid therapeutics with reduced side effects. In fact, the KOPr-mediated
dysphoria that usually accompanies the beneficial analgesic effect of KOPr
agonists has recently been attributed to the activation of the p38 mitogen-
activated protein kinase pathway, which is believed to follow arrestin recruit-
ment to the activated KOPr. This observation suggests that KOPr agonists
that selectively activate the G protein, but do not recruit arrestin, may be
more effective analgesics since they would not exhibit the adverse effects trig-
gered by the arrestin pathway.
Based on the above, understanding the structural and chemical determinants of
biased agonism at the KOPr is highly desirable as it can guide the discovery/
design of improved therapeutics. Here, we employ flexible docking of a set
of recently characterized functionally selective KOPr ligands to establish a pre-
dictive model for G protein-biased agonism at this receptor based on character-
istics of modes of interaction between the ligand and the KOPr. We apply the
resulting classifier to a large set of established KOPr agonists to assess their
ability to preferentially promote G protein coupling, arrestin recruitment, or
both.
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G protein-coupled receptors (GPCRs) are the integral membrane proteins that
detect extracellular ligands and mediate signal transduction. Binding of ligands
promotes transitions from inactive to active receptor conformations, which are
recognized by intracellular effectors. Chemically distinct ligands may trigger
different signaling responses by altering dynamics of the receptor. We devel-
oped a single-molecule fluorescence system to observe conformational switch-
ing of the b2-adrenergic receptor in real-time within a native-like membrane
environment. The receptor was covalently labeled with a photostable and
environmentally-responsive Cy3 fluorophore at the cytoplasmic end of either
transmembrane (TM) helix VI or helix VII. Individual receptor molecules
were incorporated in phospholipid nanodiscs, tethered to a microscope cover
slip and visualized over time by total internal reflection fluorescence micro-
scopy. We observed spontaneous transitions of TM helices VI and VII between
inactive and active conformations, even in the absence of any ligands. Studies
of ligands that span a comprehensive range of pharmacological efficacies
showed that full agonists shorten the time spent in the inactive conformations
and prolong the time in the active conformations, leading to an increased pop-
ulation of active species, while an inverse agonist prolonged the time spent in
inactive conformations. These observations provide new insights into the
mechanism of GPCR activation and the molecular basis for the variable phar-
macological efficacies of different drug molecules.
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G-protein-coupled receptor (GPCR) crystal structures reveal exquisite details
of interactions between amino acids and bound ligands. However, little isknown about the pathways by which ligands enter their binding sites. Binding
pathways are essential determinants of association and dissociation rates and
thus underlie kinetic selectivity, a phenomenon in which a ligand primarily
affects a particular receptor despite having similar binding affinity for several
closely related receptors. Protease-activated receptor 1 (PAR1) is a GPCR
whose endogenous agonist is a tethered, water-soluble peptide generated by
thrombin cleavage. By contrast, the PAR1-specific antagonist vorapaxar is a
lipophilic small molecule that binds in a pocket almost entirely occluded
from extracellular solvent.
Based on temperature-accelerated molecular dynamics simulations, we hypoth-
esize that vorapaxar enters the PAR1 binding pocket from the lipid bilayer be-
tween transmembrane helices 6 and 7 (TM6 and TM7). To test this hypothesis,
we take a chemical biology approach and synthesize vorapaxar derivatives with
alkyl chains extending along the predicted binding pathway. In cell signaling
assays, we find that the on-rate for vorapaxar derivatives with increased bulk
between TM6 and TM7 is no slower than that of vorapaxar. These data indicate
that vorapaxar likely enters the binding pocket from the lipid bilayer, through
the cleft between TM6 and TM7. While other groups have reported experi-
mental evidence that retinal binds to rhodopsin through a channel from the lipid
bilayer, our study provides the first such data for a ligand binding to a peptide
GPCR. Membrane drug entry mechanisms, such as the pathway we describe for
vorapaxar binding to PAR1, may be important for understanding kinetic selec-
tivity of lipophilic GPCR ligands and may inform selective drug design.
1760-Plat
Single Molecule Imaging of M2 Muscarinic Receptors in Live Heart
Explants
Gregory I. Mashanov1, Tatiana A. Nenasheva1, Ross A. Breckenridge2,
Nigel J.M. Birdsall1, Justin E. Molloy1.
1Physical Biochemistry, MRC National Institiute for Medical Research,
London, United Kingdom, 2MRC National Institiute for Medical Research,
London, United Kingdom.
TIRF microscopy allows us to visualize individual fluorophores in living cells.
We have developed automated algorithms to detect and track thousands of in-
dividual molecules and have studied GPCRs (G-protein coupled receptors)
tagged with fluorescent ligands or fluorescent proteins in live cultured cells
and freshly dissected tissue slices.
We have found that M1 and M2 muscarinic receptors diffuse freely at the
plasma membrane with their mobility dependent upon both cell-type and tem-
perature. The mobility of M2 receptors tagged with the fluorescent antagonist
(Cy3B-telenzepine) matches the mobility of M2-GFP molecules imaged under
the same conditions. Fluorophore tracking allowed direct observation of tran-
sient homo-dimerisation of M1 and M2 receptors which we confirmed using
two-color imaging. At a membrane receptor density of 2 mm2, 30% of recep-
tors were dimeric and the dimer lifetime was ~1 s1.
We have found that only ~10% of isolated primary cardiomyocytes and cells in
the mice heart slices expressed M2 receptors on the detectable level. The recep-
tors undergo unrestricted diffusion and therefore were evenly distributed across
the cell membrane. The M2 density in freshly isolated embryonic cardiomyo-
cytes was ~1 mm2, increasing at birth to ~3 mm2 and decreasing back to
~1 mm2 after birth. Whilst some M2 receptors formed reversible dimers the
majority were monomeric. The receptor mobility was approximately 4-times
faster in freshly dissected heart slices (0.6 mm2 s1) than in cultured primary
cardiomyocytes. Knowing receptor mobility and density we used Monte Carlo
simulations to estimate an encounter rate of 5-10 collisions per second. This
may explain the observed electrophysiological latency between the application
of acetylcholine and GIRK channel opening.
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The CD14 co-receptor is specialized for recognition of bacterial lipopolysac-
charide (LPS). On the surface of macrophages and other immune cells, it trans-
fers LPS and its bioactive component lipid A to the MD-2 protein in complex
with Toll-Like Receptor 4 (TLR4), and is hence crucial in activating the innate
immune system via the TLR4 signalling pathway. In the case of severe infec-
tions, lipid A can cause sepsis through over-activation of the immune
response, leading to multiple organ failure and death, and has become a major
target for anti-septic drugs. Unfortunately, the mechanism by which lipid A
is transferred to CD14, and the detailed mode(s) of associated binding, are
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simulation approaches to uncover the mechanism by which lipid A is trans-
ferred to, interacts with and binds to a hypothesized amino-terminal pocket
in CD14. We modelled the interactions and dynamics of CD14 in the presence
of a range of lipid ligands, including control fatty acid systems, and lipid A in
monomeric and aggregate/micelle forms. These simulations were run in order
to observe the spontaneous ligand binding process, and have subsequently
been extended to establish the thermodynamics of ligand recognition. Our re-
sults emphasise the dynamic nature of the amino-terminal pocket which allows
it to adapt its volume to widely varying ligand size, consistent with the broad
specificity of CD14. We have also identified a possible ligand gating mecha-
nism consistent with available NMR data, and key sites that may be essential
for LPS/lipid A binding which may ultimately be targeted by novel anti-septic
drugs.
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Mutations within the epidermal growth factor receptor (EGFR/erbB1/Her1)
are often associated with carcinogenesis. Specific mutations common in
non-small cell lung cancer (NSCLC), including EGFR-L858R and EGFR-
DL747-P753, lead to ligand-independent phosphorylation, however the molec-
ular mechanism by which these mutations in the EGFR kinase domain confer
constitutive activity remain unknown. Here, using multiple sub-diffraction-
limit imaging modalities, we reveal the altered behavior of NSCLC-
associated EGFR mutants within the plasma membrane_including altered
receptor dimerization, dynamics, and structure_which collectively dysregulate
receptor activity. Using multi-color single particle tracking (SPT) and Hidden
Markov Model analysis, EGFR mutants are shown to form stable dimers in the
absence of ligand and exhibit a slower mobility that is consistent with receptor
signaling. These results were confirmed using two-color, single-molecule
super-resolution microscopy (dSTORM) to visualize the spatial distribution
of receptors. Receptor clustering was quantified by localization-based cross-
correlation analysis to show ligand-induced aggregation of EGFR as well as
ligand-independent aggregation of EGFR mutants. Since the receptor ectodo-
main is known to play a critical role in dimerization, live cell FRET measure-
ments between the EGFR N-terminus and the plasma membrane was used to
quantify changes in ectodomain structure. We found that unliganded EGFR
mutants are more readily found in the extended conformation, similar to the
ligand bound wild type receptor. Therefore, mutation within the kinase domain
biases the structural equilibrium of the extracellular domain toward a dimer-
competent state.
Collectively, these data support a model where oncogenic signaling from
NSCLC-associated EGFR mutants is a result of productive dimerization be-
tween non-ligand bound receptors. Furthermore, because these mutations are
found in the kinase domain, this work introduces the concept that oncogenic
EGFR signaling may be controlled in part by a form of ‘‘inside-out’’ signaling.
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The epidermal growth factor receptor (EGFR/ErbB) family of receptor tyrosine
kinases initiates cell signaling in response to growth factors, thereby regula-
ting cell growth, migration and division. Four members comprise this family
(EGFR/HER1/ErbB1, ErbB2, ErbB3 and ErbB4), and activating mutations
in each protein are associated with severe cancers of the lung, colon, head
and neck.
ErbB proteins consist of an extracellular ligand binding domain, a single trans-
membrane alpha-helix, and an intracellular kinase domain. Structural and func-
tional studies of isolated domains of the EGFR family have revealed details of
the complex mechanism of receptor regulation. Somewhat lacking, however, isour knowledge of the full-length receptor in its native membrane environment.
Ligand binding is known to promote receptor dimerization and activation, but it
is unclear how receptor behavior is altered by the two-dimensional environ-
ment of the plasma membrane. In particular, the mechanism by which receptor
domains cooperate to transmit signals across the membrane is not well
understood.
Toward this end, we employed quantitative FRET microscopy to study dimer-
ization of EGFR family proteins in plasma membrane-derived vesicles. This
method measures FRET efficiency as a function of two-dimensional receptor
concentration in the membrane. We investigated four receptor pairs: homo-
dimers of ErbB1, ErbB2, and ErbB3, as well as heterodimers containing
ErbB2 and ErbB3. We first observe that the isolated transmembrane (TM)
domains have an intrinsic propensity to associate. Next, we demonstrate
that the extracellular domains function to prevent TM domain interactions.
Finally, we show that the intracellular domains alone are sufficient to drive
receptor dimerization in the absence of ligand. Dimerization occurs in a
concentration-dependent manner, and ligand shifts this threshold to low recep-
tor concentration. Importantly, both of these dimerization events occur over a
physiologically relevant concentration range.
Platform: DNA Structure
1764-Plat
Solid-To-Fluid DNA Transition Inside HSV-1 Capsid Close to the Temper-
ature of Infection
Alex Evilevitch1, Udom Sae-Ueng1, Dong Li1, Xiaobing Zuo2,
Jamie Huffman3, Fred Homa3, Donald Rau4.
1Physics, Carnegie Mellon University, Pittsburgh, PA, USA, 2Argonne
National Laboratory, Argonne, IL, USA, 3School of Medicine, Univ. of
Pittsburgh, Pittsburgh, PA, USA, 4National Institute of Health, Bethesda,
MD, USA.
DNA in the human Herpes simplex virus type 1 (HSV-1) capsid is packaged
to a tight density. This leads to tens of atmospheres of internal pressure
responsible for the delivery of the herpes genome into the cell nucleus. In
this study we show that despite its liquid crystalline state inside the capsid,
the DNA is fluid-like which facilitates its ejection into the cell nucleus during
infection. We found that the sliding friction between closely packaged DNA
strands, caused by interstrand repulsive interactions, is reduced by the ionic
environment, mimicking that of epithelial cells and neurons susceptible to
herpes infection. However, variations in the ionic conditions corresponding
to neuronal activity can restrict DNA mobility in the capsid, making
it more solid-like. This can inhibit intranuclear DNA release and interfere
with viral replication. In addition, the temperature of the human host
(37C) induces a disordering transition of the encapsidated herpes genome
which reduces interstrand interactions and provides genome mobility required
for infection.
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Over the course of its life cycle, a cell’s DNA undergoes many carefully
orchestrated topological changes, which facilitate vital cellular processes
such as replication and transcription. Consequently, unresolved conforma-
tional defects in the structure can interfere with critical interactions, and
may result in genetic anomalies that culminate in cell death. As a result,
DNA has become the target for numerous anti-cancer treatments which seek
to induce structural changes to inhibit tumor growth [1, 2]. The development
of innovative anti-cancer treatments can be greatly enhanced by high-
throughput low-cost methods to characterize their effects on DNA topology
[3]. In this study, we use Si3N4 solid-state nanopores to investigate changes
in circular DNA topology induced by intercalation of ethidium bromide
(EtBr). Our measurements reveal three distinct current blockade levels and
a six-fold increase in translocation times for EtBr treated circular DNA as
compared to untreated circular DNA. We attribute these increases to changes
in the supercoiled topological state hypothesized to be branched or
looped structures formed in the circular DNA molecule. Further evidence
of the conformational changes is demonstrated by qualitative atomic force
